Chemistry and clinical biology of the bryostatins - PubMed (original) (raw)
Review
Chemistry and clinical biology of the bryostatins
R Mutter et al. Bioorg Med Chem. 2000 Aug.
Abstract
Bryostatins are a class of antineoplastic compounds isolated from the bryozoans Bugula neritina. A wide range of scientific research is currently underway, studying different aspects of the bryostatins. In this review we try to summarize the latest findings, including all the topics involved, from marine biology to medicinal chemistry.
Similar articles
- Cytotoxic Bryostatin Derivatives from the South China Sea Bryozoan Bugula neritina.
Yu HB, Yang F, Li YY, Gan JH, Jiao WH, Lin HW. Yu HB, et al. J Nat Prod. 2015 May 22;78(5):1169-73. doi: 10.1021/acs.jnatprod.5b00081. Epub 2015 May 1. J Nat Prod. 2015. PMID: 25932671 - Antineoplastic agents. 340. Isolation and structural elucidation of bryostatins 16-18.
Pettit GR, Gao F, Blumberg PM, Herald CL, Coll JC, Kamano Y, Lewin NE, Schmidt JM, Chapuis JC. Pettit GR, et al. J Nat Prod. 1996 Mar;59(3):286-9. doi: 10.1021/np960100b. J Nat Prod. 1996. PMID: 8882431 - Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review.
Raghuvanshi R, Bharate SB. Raghuvanshi R, et al. Curr Top Med Chem. 2020;20(12):1124-1135. doi: 10.2174/1568026620666200325110444. Curr Top Med Chem. 2020. PMID: 32209043 Review. - The clinical development of the bryostatins.
Clamp A, Jayson GC. Clamp A, et al. Anticancer Drugs. 2002 Aug;13(7):673-83. doi: 10.1097/00001813-200208000-00001. Anticancer Drugs. 2002. PMID: 12187323 Review.
Cited by
- Synthetic Studies Toward Bryostatin 1: Preparation of a C(1)-C(16) Fragment by Pyran Annulation.
Keck GE, Welch DS, Poudel YB. Keck GE, et al. Tetrahedron Lett. 2006 Nov 20;47(47):8267-8270. doi: 10.1016/j.tetlet.2006.09.094. Tetrahedron Lett. 2006. PMID: 17404602 Free PMC article. - Synthesis of seco-B-ring bryostatin analogue WN-1 via C-C bond-forming hydrogenation: critical contribution of the B-ring in determining bryostatin-like and phorbol 12-myristate 13-acetate-like properties.
Andrews IP, Ketcham JM, Blumberg PM, Kedei N, Lewin NE, Peach ML, Krische MJ. Andrews IP, et al. J Am Chem Soc. 2014 Sep 24;136(38):13209-16. doi: 10.1021/ja507825s. Epub 2014 Sep 10. J Am Chem Soc. 2014. PMID: 25207655 Free PMC article. - Conformation-activity relationships of polyketide natural products.
Larsen EM, Wilson MR, Taylor RE. Larsen EM, et al. Nat Prod Rep. 2015 Aug;32(8):1183-206. doi: 10.1039/c5np00014a. Nat Prod Rep. 2015. PMID: 25974024 Free PMC article. Review. - Natural neo acids and neo alkanes: their analogs and derivatives.
Dembitsky VM. Dembitsky VM. Lipids. 2006 Apr;41(4):309-40. doi: 10.1007/s11745-006-5103-9. Lipids. 2006. PMID: 16808146 Review. - Bryostatin-1: pharmacology and therapeutic potential as a CNS drug.
Sun MK, Alkon DL. Sun MK, et al. CNS Drug Rev. 2006 Spring;12(1):1-8. doi: 10.1111/j.1527-3458.2006.00001.x. CNS Drug Rev. 2006. PMID: 16834754 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources